Free Trial
ASX:ADN

Andromeda Metals (ADN) Stock Price, News & Analysis

Andromeda Metals logo

About Andromeda Metals Stock (ASX:ADN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6.96 million shs
Average Volume
N/A
Market Capitalization
A$27.41 million
P/E Ratio
N/A
Dividend Yield
2.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Andromeda Metals and its competitors with MarketBeat's FREE daily newsletter.

ADN Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
Andromeda Metals Reveals Top 20 Option Holders
See More Headlines

ADN Stock Analysis - Frequently Asked Questions

Andromeda Metals Limited (ASX:ADN) posted its quarterly earnings data on Tuesday, March, 13th. The company reported $0.00 earnings per share (EPS) for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Andromeda Metals investors own include Artemis Resources (ARV), AstraZeneca (AZN), Docusign (DOCU), Estee Lauder Companies (EL), Grafton Group (GFTU), HSBC (HSBA).

Company Calendar

Last Earnings
3/13/2018
Today
8/25/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Other Industrial Metals & Mining
Sub-Industry
Electrical Equipment
Current Symbol
ASX:ADN
CIK
N/A
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$9.56 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
0.00%
Return on Assets
-3.74%

Debt

Debt-to-Equity Ratio
0.38
Current Ratio
2.26
Quick Ratio
14.60

Sales & Book Value

Annual Sales
A$2 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
17.67
Book Value
A$0.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,390,000,000
Free Float
N/A
Market Cap
A$27.41 million
Optionable
Not Optionable
Beta
1.59
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:ADN) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners